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ABSTRACT 
Unlike intact abdominal aortic aneurysm (iAAA), ruptured abdominal aortic aneurysm (rAAA) 
is a lethal condition demanding immediate resuscitation and surgical intervention. Where the 
former is a silent disease with slow expansion of the infrarenal aorta, rAAA is symptomatic with 
abdominal/back pain and possibly even hemorrhagic shock. Repair of an iAAA has low mortality 
rates while repair of rAAA is associated with much higher complication rates and postoperative 
mortality. 
In Sweden, the prevalence of iAAA amongst 65-year-old men is 1.2–1.5 %. Every year 175–200 
patients with rAAA are treated at hospitals across the country. With decreasing autopsy rates, 
the overall number of ruptures remains unknown and many studies lack the reporting of 
untreated patients.  
The overall aim of this thesis was to investigate less commonly studied aspects of AAA 
epidemiology, with particular emphasis on rAAA; from broad epidemiology with time trends in 
incidences and repair modality, to population-based investigations of the prevalence of 
previously known AAA in patients with rupture. Furthermore, the effect of sex and 
socioeconomic position (SEP) on the severity of disease and outcome of repair was studied.  
Studies I and II are retrospective population-based studies of all individuals with a rAAA 
admitted to a hospital in the Stockholm county region and Gotland county, 2009–2013. The 
aim of these studies, based on a study cohort of all admitted rAAA patients, was to explore 
the proportion of untreated rAAA patients, and of previously diagnosed AAA patients that 
are found in a cohort of ruptured patients. Study I demonstrated that the majority (75 %) of 
patients with rAAA who reach an emergency department will undergo corrective repair. 
Repair rates, modality of repair and outcome were similar between the sexes. Study II 
showed that one third of patients with rAAA had a previously known aneurysm and the most 
common reasons for not having undergone repair included denied elective surgery (36 %), 
missed surveillance (31 %) and patient choice (18 %). 
Study III is a population-based study of 41,222 patients nationwide that aimed to investigate if 
low SEP was associated with presenting with a rAAA rather than iAAA and with poorer repair 
outcome. Also, the study describes time-trends in AAA incidence and rAAA mortality for 2001–
2015. After adjustment for age, sex and comorbidity a continued strong association between 
low SEP and the risk of presenting with a rAAA and dying within 90 days of repair persisted.  
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Study IV, also a nationwide study, included 10,724 patients with rupture. Using a propensity-
score-matched analysis, women were matched with men and an analysis was performed to 
determine whether: women are less often treated for their rAAA; women are less often treated 
with EVAR; outcome after repair is worse for women compared to men. The average treatment 
effect for women was -0.08, p<.001 for receiving repair and 0.086, p<.001 for 90-day mortality. 
However, when adjusting for postoperative complications, only short-term mortality was 
higher in women. No difference in repair modality was seen between the sexes. Complication 
rates were similar between the sexes. Time trends indicate a decrease in the number of rAAA 
among men, especially aged 65–84, in contrast to the unchanged rates in women.  
The incidence of AAA overall and rAAA specifically is declining while the use of EVAR in ruptures 
is increasing. On a regional level, sex differences in rAAA were not evident but nationwide sex 
differences were prominent and alarming. Apparent positive trends in the care of men with 
rAAA can be found that are partly associated with the implementation of screening and with 
improved cardiovascular prevention in the population. However, the results unfortunately do 
not reflect equally in the female population. Alarmingly, our results emphasize the presence of 
inequality in the health care system for women and those with low income and a low level of 
education.  
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POPULÄRVETENSKAPLIG SAMMANFATTNING 
Stora kroppspulsådern (latin: aorta) är kroppens största blodkärl och transporterar blod direkt 
från hjärtat ut till kroppens alla organ inklusive hjärnan, njurarna, tarmarna samt 
extremiteterna (armar och ben). Abdominala (buk) kroppspulsådern, som denna avhandling 
berör, löper från diafragman ner till delningen till de två stora bäckenkärlen .  
Abdominala aortan kan, av olika anledningar, långsamt börja vidgas, som en ballong. Denna 
process sker oftast helt i det dolda utan att ge individen några som helst symptom. De tre 
största riskfaktorerna för denna utveckling är rökning, hög ålder och manligt kön. När 
abdominala aortan vuxit till 3 cm i diameter kallas det abdominalt aortaaneurysm (AAA), som 
helt enkelt betyder utvidgning av aortan. När man utvecklat ett AAA så fortsätter det oftast att 
öka i storlek, med cirka 2,5 mm/år. Baserat på kunskap från flera större internationella studier 
är rekommendationen att man ska överväga kirurgisk behandling av patienter med AAA när 
aneurysmet vuxit till 5–5,5 cm i diameter. Man bedömer då att risken för att den ska spricka 
(rupturerat AAA, rAAA) och orsaka en livshotande blödning är större än riskerna med 
behandling. Har patienten hög risk för kirurgiska komplikationer, till exempel svår 
hjärtsjukdom, kan behandlingsgränsen höjas. De patienter som behandlas med ett planerat 
kirurgiskt ingrepp för sitt AAA har låg komplikationsfrekvens och bra överlevnad. De patienter 
som inkommer med ett rAAA har mycket sämre överlevnad. 
I dag finns två olika metoder att välja mellan vid operation av ett AAA/rAAA. En öppen 
operation innebär att patienten sövs och man öppnar buken från bröstbenets nedre utskott 
hela vägen till blygdbenet och kroppspulsådern ersätts med ett tubformad syntetiskt material. 
En endovaskulär metod (EVAR) finns också att tillgå. Denna innebär att man via små nålstick i 
ljumskarna leder fram smala vajrar med klädda med en protes som man löser ut på insidan av 
aortan och på så sätt täcker för aneurysmet/rupturen och leder blodet rätt. En av fördelarna 
med EVAR är att ingreppet går att utföra i lokalbedövning.  
I vår första studie undersöktes hur stor andel av personer som inkommer med rAAA som 
erbjuds kirurgisk intervention, och hur den gruppen skiljer sig från de obehandlade med 
avseende på till exempel ålder och könsfördelning. Vi fann att en mycket större andel av 
patienter som inkommer med rAAA behandlas med kirurgisk intervention än det som tidigare 
beskrivits i litteraturen. De som nekas behandling var äldre, men kvinnor behandlades i lika hög 
utsträckning som män.  
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Den andra studien ämnade till att undersöka andelen tidigare kända AAA hos patienter som 
söker med rAAA på en akutmottagning i Stockholms läns landsting. Anledningar till att man inte 
behandlade patienten innan rupturen hann ske undersöktes. En tredjedel av patienterna med 
rAAA hade ett tidigare känt AAA som av olika anledning hade missats i uppföljningen i vården 
vilket tyder på brister i samordningen kring AAA-patienter i länet.  
Den tredje studien är en nationell studie som undersökte sambandet mellan låg 
socioekonomisk position (SEP) och risk att man inkommer med ruptur i stället för ett icke-
rupturerat AAA första gången man får sin AAA diagnos. Vidare undersöktes sambanden mellan 
låg SEP och överlevnad efter behandling för rAAA. Här sågs att låg SEP var associerat med högre 
risk att söka med rAAA vid första diagnosen och sämre överlevnad efter åtgärd.  
Den fjärde och avslutande studien återkom till könsskillnader vid rAAA. Här användes ett 
landsomfattande material på över 10 000 patienter med rAAA och fynden kan delas upp i tre 
delar; 1. Kvinnor erhåller i lägre grad behandling vid rAAA än män. 2. Inga skillnader i typ av 
behandlingsmetod vid rAAA sågs mellan könen och 3. Kvinnor har sämre överlevnad, inom 
främst 30-dagar från operation. 
Tillsammans belyser dessa fyra studier områden inom kärlkirurgin och AAA-sjukdom som 
tidigare inte förstärkts eller belysts med särskilt fokus på utsatta grupper i samhället. 
Förhoppningsvis leder resultaten oss ett steg framåt i förbättringen av vården för patienter 
med AAA.  
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2 INTRODUCTION 
2.1 HISTORICAL BACKGROUND 
Deciphering the historical evolution of abdominal aortic aneurysm (AAA) disease and trailing 
the different methods of treating these “jumping vessels”, as they were first described in the 
Ebers Papyrus dating back to 1550 BC, one soon realizes that what is modern and considered 
a break-through in medical science, is quickly forgotten and discarded when the next break-
through comes along. From ancient rants to complete ligation of the aorta, followed by 
inducing fibrosis using cellophane. The latter method was used when surgeons treated Albert 
Einstein’s AAA in 1948. He later died from a rupture seven years later.1 Following that, surgeons 
and scientists from all over the world contributed to the evolution and refinement of treating 
AAAs. French surgeon Dubost performed the first successful resection of an AAA with 
restoration of blood flow using a homograft in 19512 and later that decade the use of vein 
grafts and vinyl tubes for the repair of AAA were reported.3, 4 Coming to the agreement to 
actually treat AAA was monumental but reaching a consensus on when to treat is still in some 
aspects a matter of dispute. However remarkable the evolution in medical engineering for 
repair options for AAA was in the past, it is only in the last two decades that its repair and 
outcome has gone through a huge reform. After Volodos in 1986 and Parodi in 1991 described 
an endovascular approach to treating AAA, one might say the Rubicon was crossed.5, 6 
Outcome after repair of AAA has improved since then and more ruptures are now prevented 
on a national level with early detection strategies such as nationwide screening programs and 
meticulous surveillance regimes, as well as with cardiovascular risk optimization. 
 
With that said, many questions regarding ruptured abdominal aortic aneurysm (rAAA) remain 
unanswered and unexplored. Hopefully and humbly, this thesis aims to answer some of these 
questions and shed light on previously uncharted epidemiological aspects of the rAAA. 
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2.2 DEFINITIONS, ANATOMY AND PATHOPHYSIOLOGY 
2.2.1 Definition and anatomical landmarks 
For the abdominal aorta a size more than or equal to 30 millimeters (mm) in men is often 
recognized as the definition of an AAA.7, 8 This definition is based on ultrasound diameters with 
a sensitivity of 67 % and a specificity of 97 % in predicting the need for AAA repair within ten 
years.9 Some studies have suggested 27 mm to be an adequate definition in women.7, 10 
Another accepted way of defining an arterial aneurysm is to assess its size compared to the 
size of an unaffected adjacent segment of the same vessel. A local widening of >1.5 times its 
expected normal size including all layers of the artery (intima, media and adventitia) defines it 
as an aneurysm.11-13 The different ways of defining an AAA cause difficulties in comparing 
studies of the disease. The abdominal aorta is delimited cranially by the diaphragm, and is 
commonly further divided into the suprarenal (above the renal arteries) and infrarenal 
segments. Thus, there are suprarenal and infrarenal AAAs. Juxtarenal AAAs extend to the level 
of the renal arteries. The aortic bifurcation is the lower boundary. For the purpose of this thesis, 
the term AAA refers to the infrarenal AAA, figure I. 
 
 
Figure I. Anatomical image of the intact abdominal aortic aneurysm (AAA) to the left and the ruptured AAA to the 
right. 
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2.2.2 Pathophysiology  
The widening of the abdominal aorta is caused by a complex and not fully understood pathway 
leading to the weakening of the aortic wall with all three of its layers affected in the process. 
Proteolytic enzymes involved in inflammatory processes cause degradation of collagen and 
elastin in the aortic media as well as apoptosis of smooth muscle cells in the aortic wall.14 
Matrix metalloproteinases (MMPs), cytokines and reactive oxygen species are possible 
participants in this inflammatory degeneration of the aortic wall. The widened aortic wall 
contributes to turbulent blood flow and promotes the formation of intraluminal thrombus. This 
phenomenon is common in the pathophysiology and anatomy of an AAA and seems to play an 
important role in further weakening and degradation of the aortic wall.15-17 Still, the true and 
full pathophysiology of AAA development remains unknown.  
2.2.3 Morphology  
The anatomical shape of an aneurysm further divides it into subgroups of fusiform and saccular 
aneurysm. The fusiform aneurysm is the most common shape in AAA and is seen as a 
symmetrical bulge involving the full circumference of the aortic wall, figure II. The common 
perception of saccular aneurysms as high risk aneurysm with higher rupture tendencies has 
rarely actually been studied. In an American setting, a study found similar growth rates in 
saccular aneurysms as in fusiform.18 However, the current recommendation is that saccular 
aneurysm ought to be treated at smaller diameter than fusiform.19, 20 Dilation of all three layers 
of the arterial wall defines the aneurysm as a “true” aneurysm. This is to separate it from false 
aneurysm, also known as pseudo-aneurysm. These are often formed after a penetrating 
trauma or blunt injury and occur as blood escapes the lumen of an artery to create a localized, 
encapsulated hematoma either between the media and adventitia or in the surrounding 
tissues. 
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 Figure II. A fusiform abdominal aortic aneurysm (left) and saccular AAA (right) 
 
2.3 EPIDEMIOLOGY 
2.3.1 Intact AAA – prevalence and risk factors 
AAA is fairly rare in the general population and its prevalence seems to be decreasing21 but it 
is still a burden on healthcare globally.22 During the 20th century it was a disease on the rise 
with high mortality causing the vascular community to take action, conducting large 
randomized trials and cohort studies to reduce the knowledge gap of the disease.23, 24 Now in 
the 21st century we are starting to see a reversed trend in epidemiology and mortality.25-27 
Large randomized screening studies have reported a prevalence of around 4–7.6 % amongst 
men aged 64 or higher.28, 29 However, these data are outdated and more recent national 
studies in Sweden report on a much lower prevalence, not more than 1.5 % in 65-year-old 
men.26, 30, 31 Approximately 2,000–2,500 new cases of AAA are seen each year in Sweden 
compared to 10,000 new cases of prostate cancers or 25,000 new heart infarctions annually.32 
The main risk factors associated with the development of AAA include smoking, advanced age, 
male sex and heritability.33-37 Long-time smokers have been shown to have an up to eight-fold 
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increased risk of developing an AAA compared to never-smokers and the risk decreases with 
the number of years after smoking cessation38-40 but increases with female sex.41 The risk of 
developing AAA increases with age in both men and women.33, 42 AAA has a much higher 
prevalence in men than women, with a ratio of 4–6:1.34, 43-46 A meta-analysis has shown a 
higher risk of developing AAA in first-degree relatives of patients with known AAA47 with twin 
registry studies reporting on a heritability as high as 70 %.48, 49 More unclear and debated is the 
role of hypertension50, 51, serum-lipid configuration50-52 and atherosclerosis24, 53 in the 
development of an AAA. An inverse association between diabetes and aneurysm growth has 
been shown.39 The high prevalence of AAA in patients with coronary artery disease (CAD) 
indicates similar risk profiles and possible targets for sub-group screening.54  
2.3.2 Ruptured AAA – prevalence and risk factors 
Describing true epidemiological data on rAAA provides some difficulties. A proportion of 
patients, reported at around 50 %55, 56, will die immediately at home. Estimations of out-of-
hospital deaths are often based on death certificates57 or autopsy reports that are declining56-
61. With that in mind, incidence of rAAA is reported at 5.6–17.5 per 100,000 person-years56, 58, 
62, 63 with an overall mortality of rAAA around 80–94 %.56, 64, 65 There has been, however, a 
decrease in mortality from rAAA reported since 1995.27, 66, 67 This is sometimes accredited to a 
decreasing prevalence of AAA in the population which can be associated with changing 
smoking habits.26, 68, 69 Also, the implementation of screening programs for AAA has been 
suggested as another cause of this decrease.31 It is only in recent years that studies on rAAA 
have included data on both treated and untreated patients70, 71, but there is an obvious need 
for further study in this field to answer questions such as how many of the AAA that rupture 
were previously known and what the reasons for non-repair at initial time of diagnosis were. 
The RESCAN study, a meta-analysis of >15,000 individuals with AAA, proposed different risk 
factors for growth and rupture, suggesting female sex, smoking and high blood pressure as risk 
factors for rupture and smoking as a risk factor for aneurysm growth.39 Risk factors for 
aneurysm expansion also include high blood pressure, while diabetes and peripheral vascular 
disease seem to have a protective effect.38, 44, 45 Also, hereditary AAA is associated with more 
rapid growth and higher rupture rate72, 73 as well as rupture at smaller aneurysm diameter and 
at lower age.73 The one variable used in clinical practice to predict the risk of rupture is the 
aneurysm size, or more precisely the maximum aneurysm diameter.44, 45, 74 In a prospective 
study of 198 men with AAA of at least 55 mm in diameters, annual rupture risks were estimated 
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at 10 % for aneurysms 55–69 mm in diameter but >33 % for aneurysms >70 mm.74 This is in 
contrast to a more recent pooled analysis of untreated AAA that suggests much lower rupture 
risks.75  
 
Women have a higher risk of rupture than men.39, 44, 46, 76 The reasons for this is debated, with 
possible weaker wall strength and a relatively higher aneurysm growth rate as two possible 
mechanisms.10, 77 The expansion rate of an AAA seems to play a role in determining the risk of 
rupture78, 79 but the influence of expansion rate on the choice to treat remains debated and it 
is not mentioned as a suggestion to treat on the basis of expansion rate in the latest guidelines 
from the American Society of vascular surgery.19 Emerging data on the possible 
underestimation of the risk of rupture in women compared to men, implicates that the use of 
similar aneurysm diameter thresholds for both sexes for repair and surveillance could explain 
the increased risk in women.80, 81 In recent years, new methods of estimating the rupture risk 
of an AAA have emerged including Aortic Size index (ASI)80, 81 and biomechanical assessments 
of wall stress.77, 82 However, the lack of prospective studies investigating these assessments 
has hindered these tools from being used in clinical praxis. Women have also been suggested 
to have a worse outcome after repair for rAAA than men.83 This has however been refuted by 
other studies71, 84-86 and the true association between female sex and outcome after repair 
remains unclear.  
 
2.4 CLINICAL PRESENTATION 
An iAAA is a silent disease; the patient rarely has any symptoms such as discomfort or pain. 
Sometimes a pulsating mass can be palpated over the umbilicus87 but the AAA is most 
commonly found en-passant in routine scans for other diagnoses or in screening programs. 
When a patient is diagnosed they are referred to a vascular clinic for an assessment of the 
aneurysm and a general clinical evaluation at the prospect of a potential repair. Most AAAs 
found are small in size and the patients are put under an ultrasound surveillance schedule 
based on large studies assessing the rupture risk in relation to the maximum diameter of the 
AAA23, 88-91, table I. These surveillance programs may differ between and within nations with 
regards to their surveillance intervals.  
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Table I. Detected aneurysm size and surveillance interval19, 20 
 
 
 
 
 
 
 
If or when the AAA grows to a maximum diameter of 55 mm, studies have shown that the 
annual risk of rupture exceeds the risks of surgical or endovascular repair.88, 92 For women, the 
threshold for repair is lower, around 50 mm.19 Preoperative planning of a patient with an AAA 
includes a computer tomography (CT) of the aorta, figure III, possible referral for optimizing 
cardio-, pulmonary- and renal status and an in-depth discussion with the patient regarding the 
different repair modalities available.  
 
 
Figure III. Three-dimensional CT angio reconstructions of intact abdominal aortic aneurysm (left), and of the same 
aneurysm after rupture (right). 
 
Aneurysm size (mm) Surveillance intervals 
25-30  Rescan after 10 years 
30-39  36 months 
40-49  12 months 
50-54  6 months 
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Unlike the iAAA that usually goes unnoticed by the patient, a symptomatic non-ruptured AAA 
presents with abdominal pain and palpable bulge in the umbilicus region but the aneurysm is 
not ruptured and hemodynamic instability is absent. A symptomatic AAA calls for prompt 
repair, however it is possible to await optimal conditions and resources for best surgical 
management and outcome.19 The rAAA is different in its presentation from both intact and 
symptomatic AAA. It is accompanied by massive bleeding and possibly hemodynamic shock. 
The classic triad of symptoms for rAAA is abdominal pain, hypertension and a palpable 
pulsating mass in the abdomen although misdiagnosis of rAAA is still an issue for emergency 
departments and their personnel.93  
2.4.1 Screening 
Initiated in 2006, screening for AAA amongst 65-year-old males is now offered on a nationwide 
basis in Sweden. Reaching national coverage in 2015, the Swedish screening program offers a 
single scan to all 65-year-old men by a letter of invitation. Similar programs are in effect in both 
the United Kingdom94 and in the US.95 Screening for AAA in the United States is offered through 
different private and government programs directed at 65- to 75-year-old men with a history 
of smoking or a family history of AAA.96 Contemporary data have demonstrated a reduction of 
AAA-specific mortality with screening as well as being cost-effective.97, 98 In the Swedish 
screening program, to prevent one premature AAA related death, the number needed to 
screen is 667.31 Furthermore, AAA-screening contributes to a lower all-cause mortality.97 With 
a three- to four-fold increased risk in rupture in women23, the implementation of female 
screening is debated but it has yet to prove reductions in rupture rates or economic viability.99, 
100  
2.4.2 Improving care of AAA patients 
One might argue that no patient with a known AAA should rupture as surveillance protocols 
and intervention criteria are designed to minimize these events. With nationwide screening 
already implemented, more Swedish men with AAA will enter the offered surveillance 
program. Some patients themselves decline elective surgery, possibly due to the operative risk 
assessment. However, when rupture occurs, a proportion of these still undergo emergency 
repair with much higher mortality and complication rates. Identifying the proportion of 
previously diagnosed AAA amongst patients with a ruptured AAA is a possible gateway into 
finding new areas in need of improvement in the overall care of the AAA-patient. Some patients 
are deemed unfit for surgery at time of initial AAA-diagnosis; this number has been reported 
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to be around 11–27 % of patients with an AAA.101, 102 Proper risk assessment is imperative in 
the preoperative phase.103 It has been suggested to use different risk score models in assessing 
operative risk104, 105 and incorporating these results when discussing surgical risk with the 
patient.19 
2.4.3 Non-operative management of rAAA 
Some patients admitted to a hospital with rAAA are deemed unlikely to survive surgical repair 
and are managed conservatively i.e. palliation. The acute setting of rAAA demands quick 
decisions and surgical judgment which is not always an easy task. Scoring systems are 
sometimes proposed as an aid in the decision making, but these have not proven sufficient or 
accurate.106 Recent studies have implied that repair of rAAA in patients >80 years old could 
give acceptable results.107-109 Following current recommendations by the European society for 
vascular surgery, decisions on non-operative management should not be based solely on 
scoring systems or on advanced age.20 A great variation in turn-down rates for rAAA patients 
exists.56, 70, 83, 108, 110, 111  
 
2.5 TREATMENT 
2.5.1 iAAA. Medical treatment and preoperative optimization  
Several drugs have been studied in an effort to find pharmaceutical treatment of aneurysm 
growth and for prevention of rupture. These include Doxycycline, Metformin, β-receptor 
blockers, ACE-inhibitors and fluoroquinolones among others.112, 113 Although studies in animal 
models or ex vivo human AAA tissue have implied possible associations, none has proven 
beneficial in clinical trials112, 114 except in an observational propensity-score matched analysis 
of fluoroquinolones.113 The true effect of this drug on AAA growth and rupture remains in 
debate, however. With the known strong association between smoking and aneurysm growth, 
smoking cessation should be recommended to all AAA patients.24, 33, 115 Optimizing overall 
cardiac, pulmonary and renal function is imperative to achieve good postoperative results. 
Although the level of evidence is low, statins are used to reduce the incidence of major 
cardiovascular events following surgical repair50, 116, 117 but not suggested to reduce the risk of 
AAA expansion and rupture.19 Antiplatelet therapy is recommended for AAA according to 
European guidelines20 but the same recommendation is not presented by the American Society 
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for vascular surgery.19 There is a lack of randomized trials investigating the effect of antiplatelet 
therapy specifically on AAA-patients, nonetheless it is used in a more pragmatic matter to 
reduce cardiovascular events during the peri- and postoperative period.118  
2.5.2 rAAA. Initial management 
The rAAA is a lethal condition and non-repair is associated with an almost certain death. The 
only treatment is surgical repair and the methods and outcome after repair is presented below. 
A limitation often seen in large randomized trials or cohort studies is the lack of representation 
of the proportion not treated at time of rupture diagnosis.70, 71 Also, the fact that those never 
reaching the hospital, dying at home with often no autopsy conducted are not taken into 
account hinders epidemiological conclusions.57 A Finnish study from 2016 reported on 27.5 % 
of their rAAA patients dying out-of-hospital and 43.2 % undergoing surgery.71 Furthermore, 
mors in tabula in patients with rAAA is a source of misclassification as they may not be 
registered properly in vascular registries or in-hospital records. 
2.5.3 Surgical intervention 
Open repair (OR) has been in practice since the 1950s.2 The procedure, performed under 
general anesthesia includes a large midline laparotomy, replacing the aneurysmatic aorta with 
interposition of a graft, excluding the aneurysm from the blood flow. Although improvements 
in surgical outcome after this high-risk procedure has been made, it was not until endovascular 
aortic repair (EVAR) was introduced in the early 1990s5, 6 that the first real competitor for the 
title of gold standard for treating AAAs arrived. By inserting an endograft through a 
transfemoral-approach using the Seldinger-technique and assisted by perioperative imaging, 
the patient’s AAA is excluded from the blood flow with minimal surgical trauma and often 
under local anesthesia, figure IV.  
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Figure IV. Images of final result after open repair (OR, left) and endovascular aortic repair (EVAR, right). Note that 
after EVAR, the aneurysm sac is still intact and left as is with risk of further enlargement and rupture despite being 
treated. 
 
Today, in a modern elective clinical setting, most patients are assessed for both types of repair 
and recommended the most suitable modality based on radiological findings of aneurysm 
anatomy and the patient’s co-morbidity status.115 A preoperative CT scan indicates if EVAR is 
feasible using different anatomical measurements including aneurysm neck, angulation and 
proximity to visceral arteries. In the Western world, trends shift between OR and EVAR. The 
Swedish vascular registry (SWEDVASC) reports annually on frequencies of repair types for AAA. 
In the report on the 2017 data it was apparent that EVAR is becoming more used in both the 
elective and acute settings. In 2017, EVAR was used in 59 % of AAA cases, compared to 47.6 % 
in 2009. For rAAA the proportion of EVAR was 45.9 % in 2017 compared to 22.5 % in 2009.119 
EVAR has increasingly become the first hand choice for treating patients with AAA and although 
less common in the ruptured setting, some centers have declared an EVAR-first strategy even 
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when a patient presents with a rAAA.120, 121 Unlike after OR, where follow up is often limited to 
a 30-day or one-year visit to the out-patient clinic, EVAR-patients are monitored through 
regular imaging with ultrasound or CT-scans to detect possible unfavorable graft dislocations 
or migration as well as possible aneurysm sac expansion that ultimately can lead to a late 
rupture.122, 123 
 
2.6 OUTCOME 
2.6.1 Outcome of surgical intervention in iAAA 
In Sweden the 30-day mortality rate in 2017 after repair for iAAA was 1.0 % and 2.1 % for 90-
day mortality.119 There are four large RCTs providing modern comparisons on outcome 
between OR and EVAR, table II. These studies have randomized patients with iAAA to OR or 
EVAR. Short term results have been in favor of EVAR; including shorter total hospital stay124 
and reduced early complication rates as well as low early mortality.125-127 However, these early 
gains do not seem to hold up as long-term results are reported. The EVAR 1 trial, carried out in 
the United Kingdom during a four-year period from 1999 to 2003, included patients deemed 
eligible for EVAR and randomized to either conventional OR or EVAR. Their short-term results 
showed 1.7 % 30-day postoperative mortality for the EVAR compared to 4.7 % in the open 
repair group.126 The long-term outcome was recently published where the benefits of short-
term outcome of EVAR was overshadowed by its inferior late survival partly due to secondary 
sac rupture (7 %) in the EVAR group.123 The American OVER-trial found the same results, with 
EVAR proving superior in short-term mortality but equal in its long-term mortality results after 
three years.128, 129 Furthermore, in their nine-year follow up study, neither survival, quality of 
life, costs or cost-effectiveness differed between OR and EVAR groups. However, their initial 
study did show other benefits with EVAR in the perihospital-period such as reduced procedure 
time, less transfusion requirements and shorter hospital stay. Unlike these other RCTs, the 
French Anevrysme de l’aorte abdominale: Chirurgie versus Endoprothese (ACE) trial found no 
early or late survival benefits with EVAR130 but did report on a higher re-intervention rate in 
the EVAR group (16 % versus 2.4 %). With these studies it is important to be aware of the 
generalizability or rather the lack of it, in interpreting the results. The proportion of women in 
the trials is often low, selection bias is an important factor for error, as well as differences in 
follow-up time between the RCTs, table II. 
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The EVAR 2 trial, designed to include patients deemed unfit for OR, investigated whether EVAR 
was superior to best medical treatment in these patients. Although it showed EVAR 
contributing significantly to a lower rate of aneurysm-related mortality, no overall survival 
benefit with EVAR compared to no intervention was found and EVAR was associated with 
increased costs due to continued surveillance and interventions.131 The long-term data from 
this trial further strengthens these results.132 Furthermore, <40 % of the studied patients were 
alive after four years and <10 % of the patients were alive after twelve years, regardless of 
EVAR or not, concluding that the majority of EVAR-2 patients had a limited life expectancy.  
 
Table II. Randomized controlled trials investigating outcome for iAAA after EVAR versus OR.  
 
 
 
 
 
 
 
 
 
 
* In-hospital mortality 
** Long-term was defined differently in the studies. EVAR 1: 6904 person-years follow-up, OVER: Three year 
follow-up, ACE: Three year follow-up (median, range 0–4.8), DREAM: 6.4 years (median) follow-up. 
 
2.6.2 Outcome of surgical intervention in rAAA 
In Sweden, the 30-day mortality rate in 2017 after repair for rAAA, was 22.5 % and the 90-day 
mortality 28.7 %.119 Three large randomized clinical trials have compared OR to EVAR with 
regard to outcome after intervention in rAAA, table III. The IMPROVE trial set in the United 
Kingdom (plus one center in Canada) included 613 patients randomized to endovascular 
strategy or OR. 30-day mortality was similar in both groups, with 35.4 % in the endovascular 
strategy group and 37.4 % in the OR group.133 A one-year outcome analysis described no 
benefits in survival for either group but earlier discharge and better quality of life (QoL) in the 
   30-day mortality Long-term** mortality 
 No of patients % Male  EVAR OR EVAR OR 
EVAR 1123, 126 1252 90.5 % 1.7 % 4.7 % 53 % 46 % 
OVER128, 129 881 99.3 % 0.5 % 3.0 % 32.9 % 33.4 % 
 ACE130 316 99 % 1.3 %* 0.6 %* 17.6 % 14.9 % 
DREAM127 351 91.7 % 1.2 %* 4.6 %* 31.1 % 30.1 % 
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endovascular strategy group.134 However, by three years EVAR was associated with a survival 
advantage but the improved QoL among EVAR patients was no longer as prominent.135 The 
French ECAR-trial showed similar results as did the Dutch AJAX trial.136 The AJAX trial 
demonstrated lower mortality rates than the other RCTs, possible due to optimization of 
logistics and centralized care in centers of expertise.136  
 
Table III. Three randomized trials for determining which of the modalities of OR and EVAR have the best 30-day 
survival. 
 
 
 
 
 
 
 
 
Regardless of the modality of repair, mortality rates are very high, especially compared to the 
mortality after repair of iAAA. Other than perioperative death due to massive hemorrhage and 
cardiac arrest, several postoperative complications contribute to these high mortality rates. 
These include multiple-organ failure, bowel ischemia, lower-extremity ischemia, 
cerebrovascular complications, renal failure and cardiopulmonary complications. A severe 
postoperative complication following rAAA repair is abdominal compartment syndrome (ASC). 
When intra-abdominal pressure increases to critical levels (>20 mmHG), the perfusion of intra-
abdominal organs decreases and ASC arises. For the rAAA patient, many risk factors for 
developing ASC are present including hemoperitoneum, open abdominal surgery, acidosis, 
coagulopathy and high age.138 Swedish contemporary data shows ASC occurring in 6.8–6.9 % 
of rAAA cases compared to 0.5–1.6 % after repair of iAAA139 but internationally the rate of ACS 
after rAAA has been reported higher.140 The effect on mortality is evident as the Swedish study 
demonstrated 30-day mortality rates at 42.4 % for treated rAAA patients who developed ASC 
and 23.5 % for those who did not.139 Interestingly, EVAR rather than OR, has been associated 
 
Type of study No of patients 
 30 day mortality 
Name of study % Male patients  OR EVAR 
IMPROVE133 Multicentre 613 78.3 % 37.4 % 35.4 % 
AJAX136 Three centers 116 85.3 % 25 % 21% 
ECAR137 Multicentre 107 90.7 % 18 % 24 % 
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with lower in-hospital morbidity following repair of rAAA.141 However this assumption is not 
fully established.142 
 
2.7 SOCIOECONOMIC POSITION 
2.7.1 What it is and how to measure it 
Socioeconomic position (SEP) is a complex term with a broad and multifaceted definition, 
figure V. The influence of SEP on overall health and burden of disease has consistently been 
deciphered and depicted, especially in the fields of cardiovascular disease143-145 and cancer 
treatment.146-148 Stratifying SEP and health often depicts the rich and wealthy enjoying a 
healthier and disease-free life, while poor, non-educated individuals suffer from more overall 
illness. Even for children of parents with low SEP this difference has been observed.149 To 
understand and correctly apply the meaning of SEP, one must first clarify the components of 
the term.  
Figure V. The Dahlgren-Whitehead rainbow 
model maps the relationship between the 
individual, their social context and community 
and the overall social condition as 
determinants of health. The individual lifestyle 
is embedded in social norms and networks as 
well as living and working conditions and finally 
surrounded by general socioeconomic, cultural 
and environmental conditions.  
 
2.7.2 Income 
The most widely used indicator of SEP is income. Income is a quantitative measurement 
allowing for a straight, non-conceptual approach and analysis. Different assessment tools are 
used based on differences in available data between nations. Determining income on an 
individual or household basis is only possible in nations with population based registries on that 
level such as in the Nordic countries and Sweden in specific. When these data are absent, other 
nations turn to different index calculations, such as the neighborhood deprivation index, often 
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seen in US studies.150 The relation between income and health has been attributed to both a 
material pathway – consumption of goods and health-promoting activities, and to a 
psychosocial mechanism where the relative social position of an individual relates to his or her 
heath status (even among the rich, the least rich feel poor and in that, they face worse health). 
One usually speaks of a social gradient, where the higher the income the better the health.151 
It has been suggested that this follows a curve-linear gradient showing that an increase in 
income has a higher effect in the low-income field while it has less effect for the already rich, 
figure VI. 
 
Figure VI. Example of a Preston curve. Here the difference in life-expectancy at birth is depicted, comparing data 
from 1970, 1990 and 2010 in the USA based on the Gross Domestic Product (GDP) per capita. (Source: Lutz W, 
Kebede E. Popul Dev Rev. 2018 Jun;44(2):343–361. doi: 10.1111/padr.12141. Epub 2018 Apr 14.) 
 
2.7.3 Relationship status – it’s complicated 
Whether or not marital status is to be viewed as a SEP variable independent of income, the 
economic impact of two possible income sources is unquestionable. In the Swedish registries, 
it is possible to extract data on disposable household income, adjusted for household 
composition, taking into account marital or cohabiting status as well as any minors living under 
the same roof. This gives a more pinpoint determination of an individual’s SEP, based on 
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income and household composition. However, the notion of living with a partner in contrast 
to living alone has its benefits of mental support, better compliance with medical advice and 
prescription drugs but also regarding overall mortality.152, 153 This has been shown to be more 
evident among men than women.154  
2.7.4 Level of education 
A person’s level of education is sometimes used as a surrogate for actual income or assumed 
SEP. A correlation between higher mortality and low educational level has been demonstrated 
in the US in cancer patients.155, 156 Also, educational level has been used to evaluate smoking 
habits and a correlation between a decline in smoking habits and higher educational level has 
been shown.157, 158 In 2016, the Public Health Agency in Sweden released its public health 
report stating that the difference in mean remaining survival years was 5.1 years longer for 
women and 5.7 years longer for men with higher educational level than for those with low 
educational level.159 Also, while men with low level of education have seen their life expectancy 
increase over the past two decades, women in Sweden with low level of education have had 
the least increase in remaining life expectancy over the last 25 years.159 Not only does low level 
of education impact health, it interacts with female sex and amplifies inequality.  
2.7.5 Index and context 
Neighborhood deprivation index is a tool developed to incorporate different aspects of SEP 
without data on an individual level.160, 161 It includes many of the factors previously described 
and more; including racial ethnicity. One of the oldest index-scoring systems for deprivation is 
the Carstairs index.162 It is based on four census indicators; low social class, lack of car 
ownership, overcrowding and male unemployment. This method has mostly been used in the 
United Kingdom and stands as a predecessor for newer census-based index systems. In 2012 
the Vancouver Area Neighborhood Deprivation Index (VANDIX) was published. It is based on 
the weighted summation of seven socio-economic variables including proportions of 
educational level, home owners, single-parent families, as well as unemployment ratio and 
income.161 
2.7.6 SEP and surgical outcome 
In surgery, and vascular surgery in particular, the correlation between SEP and surgical 
outcome has been sparsely studied with heterogeneous results. An American study 
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investigated high risk surgical procedures and found higher rates of postoperative mortality 
amongst the elderly with a lower SEP.163 A recent Dutch study including different types of 
vascular interventions demonstrated that the severity of the AAA disease (i.e. rAAA as opposed 
to iAAA) increased with lower SEP and that survival was most affected by SEP in the lowest 
income regions.164 Furthermore, a study from New Zealand investigated differences in 
outcome after AAA repair based on SEP and ethnic groups. Their results indicated both low SEP 
and being Maori as predictors of increased risk for postoperative mortality following AAA 
repair.165 Just recently, a study from the United States demonstrated an association between 
SEP and long-term mortality after repair for iAAA. 150 
 
The pathway mediating the association between SEP and health outcomes has been described 
using several theoretical models. Different entry points for the impact of SEP on health, both 
on an individual and a society level have been suggested, figure VII.166 To clarify parts of this 
model: social stratification can be seen as a reflection of how individuals aspire to reach higher 
social positions created by society, for instance through education. Differential exposure 
indicates that the exposure to different risk factors is dependent on the social position of the 
individual, such as work environment, figure VII. Depending on the SEP, individuals differ in 
their vulnerability against disease (differential vulnerability) and also in what consequences a 
disease has on the individual (differential consequences), figure VII.  
 
Figure VII. An overview of central mechanisms (to the 
left) and their associated policy entry points (center) 
related to social inequality in health. (Source: Diderichsen 
et al166). To explain this figure further, imagine a male 
individual with the lowest SEP. His SEP will expose him to 
risk factors for disease such as smoking, bad working 
environment etc (differential exposure). Furthermore 
his low SEP might allow him to fall ill more easily than 
others (differential vulnerability) and having to refrain 
from work will have greater economic consequences for him (differential consequences). Regulations can be 
performed on different levels to reduce these differential variables. For instance, regulations against smoking or 
harsh work environments (decreases exposure), providing free and easy accessible health care (decreases 
vulnerability) and offering regulated sick-leave and rehabilitation support (preventing unequal consequences).  
Social positionSocial context
Social stratification
Decreasing vulnerability
Decreasing exposure
Differential vulnerability
Differential consequences
Differential exposure
Further  social stratification
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Society Individual
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2.8 LET’S TALK ABOUT SEX 
The difference between the sexes in terms of disease onset, pathophysiology, progress and 
outcome is often debated within the field of AAA disease. AAA is considered a male-dominated 
disease with 4–6 times higher prevalence in men than in women. In a meta-analysis of the 
current prevalence of screening-detected AAA in women, the prevalence ranged from 0.31 
percent to 1.53 percent167. The conundrum with AAA in women comes in five main points. 
Firstly and secondly, (i) the risk of rupture is three times higher in women than in men44, (ii) 
women have a tendency to rupture at a smaller aneurysm diameter.80, 85 The increased rupture 
risk is sometimes credited to peak wall stress or aortic tensile strength as well as to differences 
in collagen cross-linking in the aortic wall.63, 168, 169 One explanation of the smaller aneurysm 
diameter among ruptures in women is that the ratio of aneurysm diameter to body surface 
area, (ASI), is higher at time of rupture in women than in men despite actual smaller aneurysm 
diameter.80, 170, 171 It has even been proposed that the supposed male predominance in AAA 
prevalence is due to body size differences and adjusting for this would leave only small sex 
differences in AAA prevalence.81 Thirdly, (iii) the median growth rate in women has been shown 
to be almost twice that in men independent of initial aneurysm size and age172, though this has 
been contradicted in other studies.39 Fourth, (iv) women have been shown to undergo repair 
at time of rupture less often85 with higher age and more comorbidities in women influencing 
these results.173 Finally, (v) it has been suggested that postoperative mortality after rAAA is 
higher in women compared to men, though these results are controversial and not 
homogenous.83-85, 174, 175 Part of the uncertainty in these results is the lack of women included 
in most large studies of iAAA and rAAA. 
 
2.9 MAPPING THE UNCHARTED TERRITORIES 
With all this knowledge already at our disposal, what areas of the rAAA remain to be further 
explored? The main effort must lie in continuing to reduce the rAAA incidence. Screening and 
smoking cessation will most likely be the two greatest steps in this direction; by finding the AAA 
before it ruptures with the former, and by reducing aneurysm formation and growth through 
the latter. However, there are other aspects of rAAA that need to be addressed. We know that 
many ruptures occur in patients with known aneurysms. Why are they allowed to rupture? Is 
it solely due to the patients being denied elective repair or have they actively declined that 
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option? Are there other, modifiable, reasons behind these ruptures? If SEP plays a role in 
severity of illness and mortality, maybe these groups need specific and targeted efforts both 
pre- and postoperatively to ensure improved overall health even in the socioeconomically 
deprived. RCTs in rAAA have a low proportion of women included and conclusions on sex 
differences in outcome are therefore difficult to reach. Using large retrospective cohort data 
gives a higher volume of women in these studies but the level of evidence is low due to risk of 
unadjusted confounders and both type I and type II errors. However, using a statistical method 
that aims to imitate a RCT while using retrospective observational data could possibly bridge 
the gap between the known and unknown aspects of sex differences in AAA-disease. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  39 
3 AIMS OF THE THESIS  
 
The overall aim of this thesis was to study aspects of rAAA epidemiology and improve our 
knowledge of rAAA disease with special focus on some of the more vulnerable groups in society 
prone to suffer more from inequality in health care. 
 
The specific aims were: 
 
STUDY I.  To investigate the contemporary care of all treated and untreated patients 
with rAAA admitted to a hospital, with special consideration to age and 
gender. 
 
STUDY II.  To investigate the proportion of previously known AAA among patients 
presenting with rupture and to present reasons for non-repair at initial time of 
iAAA diagnosis.  
 
STUDY III.  To study long-term trends in incidence and management of rAAA and to 
compare the SEP distribution in patients with iAAA and rAAA. A particular aim 
was to elucidate the influence of SEP on type of index diagnosis at 
presentation (iAAA or rAAA) and on the outcome after rAAA repair. 
 
STUDY IV. To investigate sex differences in repair rates and repair outcomes in rAAA 
patients. 
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4 DATA SOURCES AND METHODS 
4.1 OVERVIEW 
Table IV. Presentation of material and methods used in Studies I–IV. 
 Study I Study II Study III Study IV 
Study design Population-based, 
retrospective 
Population-based, 
retrospective 
Population-based, 
retrospective  
Population-based, 
retrospective 
Data sources Hospital charts, 
SWEDVASC 
Hospital charts Swedish NPR, Swedish 
Cause of Death 
Register, LISA 
Swedish NPR, Swedish 
Cause of Death 
Register, LISA, 
SWEDVASC 
Population Inhabitants of 
Counties of Stockholm 
and Gotland 
Inhabitants of 
Counties of Stockholm 
and Gotland 
All inhabitants in 
Sweden 
All inhabitants in 
Sweden 
N* 283 283 41,222 10,724 
Time period 2009–2013 2009–2013 2001–2015** 2001–2015 
Exposure Repair rAAA SEP Sex 
Outcome Repair rates, Sex-
inequality 
Rate of previously 
known AAA 
Time trends in 
incidence, repair 
modality, mortality. 
Index diagnosis rAAA. 
Outcome after repair 
Repair at time of 
rupture. Repair 
modality. Outcome 
after repair 
Statistical 
method 
Frequency 
distribution and 
relative proportions 
Frequency 
distribution and 
relative proportions 
Frequency 
distribution and 
relative proportions. 
Logistic regression 
Propensity-score 
matching 
Abbreviations: NPR National Patient Register, LISA Longitudinal integration database for health insurance and 
labour market studies (extracted from Statistics Sweden), rAAA ruptured abdominal aortic aneurysm, AAA 
abdominal aortic aneurysm, SEP Socioeconomic position. *N=Total number of included individuals in the study. 
**Data from 1995–2000 was also extracted to provide a 5-year diagnosis-free interval 1995–1999. The year 2000 
was excluded as we included disposable household income from the previous year of diagnosis.  
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4.2 DATA SOURCES 
Different registers have been used within the scope of this thesis and the included studies. 
4.2.1 The Swedish National Patient Register 
The Swedish National Patient Register (NPR) is composed of several registers including the 
Inpatient register, also known as the Hospital Discharge Register, and the Outpatient Register. 
It was started in 1964 and reached complete coverage by 1987. The mandatory nature of the 
register for all physicians, public and private, to deliver data to the register has led to a 99 % 
coverage of all somatic and psychiatric discharges. The register uses current ICD-codes for 
registration of both primary and secondary diagnosis and also includes mode of discharge, i.e. 
to where the patient was discharged. Each hospital discharge is keyed to the individual’s 
Personal identity number (PIN) allowing easy overview and cross-matching of all entries in the 
register for a specific individual. Although the In-patient register has an almost complete 
coverage, the Out-patient register has a coverage of around 80 % as it does not include all 
private care-givers (for public care-givers the coverage is close to 100 %). In Sweden, all 
vascular surgery procedures except venous interventions are only provided through public 
care-givers. An external validation of the NPR from 2011 describes its positive predictive value 
at 85–95 %.176  
4.2.2 The Swedish Cause of Death Register 
The Swedish Cause of Death Register (CDR) is managed by the National Board of Health and 
Welfare (NBHW) and includes data on all deaths among Swedish residents, domestic and 
abroad covering 99 % of Swedish residents. The basis for the register is the death certificate 
(dödsorsaksintyg), issued by the physician last seeing the patient and must be submitted within 
three weeks of the death. Before this, a notification of death (dödsbevis) must be issued 
immediately to the Swedish Tax Agency. Information from both these are recorded in the CDR. 
The death certificate includes the underlying cause of death; primary, secondary and so on. 
The quality of the register is said to be mainly affected by two factors; the quality with which 
the physician certifies the death and the quality in processing the death certificates and 
validating the data.177 The Cause of Death Register also couples the PIN of the individual with 
the data in the register allowing for cross-matching between different registers. Some have 
suggested that the decrease in autopsy rate in Sweden, from 50 % in the 1970s to between 7–
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15 % in 2014 has had a negative effect on the quality of the register. However, with the 
increased use of modern laboratory and imaging tools, more accurate diagnostics preceding 
the death ought to combat such deterioration.178  
4.2.3 The Swedish Vascular Register 
The Swedish Vascular Register (SWEDVASC) was started in 1987 and has grown to become a 
nationwide register with an excellent external and internal validity.179 This being said, the 
specific reporting on rAAA might be the most uncertain variable, as the acute nature of the 
disease might prompt intervention at non-SWEDVASC affiliated hospitals and misclassification 
due to mors in tabula. This would lead to an underestimation of the postoperative mortality 
rates from SWEDVASC. Although in its previous forms the register lacked nationwide coverage 
and a heavy manual paper-based registration process impaired the reporting rates, it is now, 
in its electronic form a widely used register for all vascular surgeons in Sweden. The reporting 
to SWEDVASC is, however, not mandatory from a legal or reimbursement aspect. Only treated 
patients are registered in SWEDVASC. Pre-, peri- and postoperative data is registered including 
data on comorbidity, smoking, height and weight of the patient, type of repair, type of 
anesthesia, postoperative complications as well as postoperative mortality. Beyond these, also 
QoL and Patient Reported Outcome Measures (PROM) are registered for some procedures.  
4.2.4 Longitudinal integration database for health insurance and labour market studies 
(LISA) 
The LISA database is managed by Statistics Sweden (Statistiska centralbyrån) and since its start 
in 1990 the database is annually updated with data from the labour market, educational and 
social sectors. Data is individually registered but connections to family and places of 
employment are also available. Among other data, disposable income, highest level of 
education, country of birth and place of residence are some of the data available from LISA. 
The PIN-specificity of the database allows for cross-matching with other registers from other 
register holders. 
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4.3 METHODS 
Study I and II. Participants were identified using local hospital records. The ICD-code I73.1 was 
used to identify rAAA cases. A chart review was performed of each included case and data on 
sex, repair, repair type, comorbidity and outcome after repair was extracted. The rAAA was 
verified through imaging, at intervention or in autopsy reports. For Study II a chart review was 
performed of each included case and data on previously diagnosed iAAA was extracted, as was 
the reason for non-repair at time of initial iAAA diagnosis.  
Study III. Data from the NPR and CDR was extracted for the first registered index diagnosis of 
either iAAA or rAAA. Data on disposable household income (divided into quintiles of increasing 
income Q1–Q5), and level of education was extracted and matched from Statistics Sweden and 
used as markers of SEP. Data on age, sex and comorbidities as well as time of death was also 
extracted and included in the analysis. Logistic regression was performed to assess the 
association between SEP and the outcome events. For analysis of time trends, a Mantel-
Haenszel test for trend was performed. Analysis for missing data >5 % was proceeded with 
multiple imputation by chained equations. 
Study IV. The NPR and CDR were scanned for all cases of rAAA during 2001–2015. Data on SEP 
was extracted from Statistics Sweden and cross-matched. Data on age, sex, year of rupture and 
comorbidities as well as time of death was also extracted and included in the analysis. Similarity 
between subjects is based on estimated treatment probabilities, known as propensity-score 
(PS). The treatment effect is computed by taking the average of the difference between the 
observed and potential outcomes for each subject. Matching was performed with a 1:3 ratio; 
each female was matched to the nearest three male individuals if the distance between the PS 
of these individuals was no greater than 0.08 (caliper). Average treatment effect (ATE) was 
calculated in this model. For a subgroup analysis on postoperative mortality, including 
postoperative complications in our PS-model, patients from 2009–2015 were included and the 
caliper was raised to 0.15.  
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4.4 ETHICAL CONSIDERATIONS 
All studies in this thesis were approved by the Regional Ethical Review Board in Stockholm. For 
Study I and II, the nature of the rAAA disease made informed consent from the subject 
impossible. All data was initially created anonymously with a link between the data and the PIN 
stored according to the rules and regulations provided by Karolinska Institutet. All the data for 
Study I and II was presented at a group level. For Study III and IV, the linking of data on an 
individual between registers was performed by the NBHW before the data was anonymously 
handed over to our research group making a reverse identification impossible.  
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5 RESULTS AND DISCUSSION 
5.1 RESULTS 
Study I and II. These two studies included 283 individuals with rAAA. Three out of four patients 
were male (n=214; 76 %). Mean age of the whole cohort of patients was 78.7 ± 8.9. Women 
were older (82 vs 78 years, p<.001), had smaller AAA diameter (74 vs 83 mm, p=0.006) and 
lower BMI (22.4 vs 28.4, p=0.002) compared to men. Study I found no difference between the 
sexes in repair rates or the use of EVAR. No difference was noted in postoperative mortality. A 
high proportion of patients admitted to a hospital with rAAA, (75 %) underwent repair, figure 
VIII.  
 
 
Figure VIII. All admitted patients with rAAA (n=283), their repair rates (brown), modality of repair (green) and 
mortality within 30 days after repair (red).  
25 %
75 %
EVAR 27 %
OR 73 % Alive 62 %
Dead 38 %
28 %
72 %
EVAR 34 %
 OR 66 % Alive 64 %
Dead 36 %
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Women
Treatment modalityTreatment rates
Alive 62 %
Dead 38 %
24 %
76 %
EVAR 25 %
OR 75 %
30-day mortality
Men
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Study II showed that the proportion of previously detected aneurysm was 30 % (n=85). Four 
principal reasons for the decision not to treat at the time of aneurysm detection were 
identified: denied elective surgery due to comorbidity/high age (n=31); missed surveillance 
(n=26); patients’ choice (n=15); denied elective surgery due to aneurysm size (n=11). In two 
cases the reason for non-repair or inadequate surveillance was not clear, figure IX. 
 
 
Figure IX. Chart overview of individuals with a previously known abdominal aortic aneurysm (AAA) among rAAA 
patients and reasons for non-repair at initial AAA diagnosis.  
 
Study III. From 2001 to 2015, a total of 41,222 individuals were diagnosed with either an iAAA 
(n=33,254; 80.7 %) or a rAAA (n=7,968; 19.3 %) and included in the analysis, table V. The overall 
proportion of women was 21.7 %. The incidence of iAAA per 100,000 inhabitants aged >45 
years peaked from 45.9 in 2001 to 73.5 in 2011 and later dropped to 51.4 in 2015. Time trends 
showed a steady decrease in the absolute number of cases of rAAA, from 2,505 in the earliest 
time-period to 1,679 in the latest (p<.001), figure X. The use of EVAR increased, especially 
during the last 9 years (2007–2015), figure X. During the study period, postoperative survival 
after repair for rAAA improved and the study population had an increase in mean age from 
75.7 in 2001 to 78.6 in 2015 (p<.001). 
 
 
Denied elective surgery
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Table V. Demographics of included individuals (n=41,222) in Study III, presented in quintiles of disposable 
household income; Q1 representing the poorest and Q5 the richest quintile.  
Abbreviations: iAAA: intact abdominal aortic aneurysm, rAAA: ruptured abdominal aortic aneurysm, SD: standard 
deviation, COPD: chronic obstructive pulmonary disease, *5808 missing cases. Of individuals with a rupture at 
index-event, 2,187 had missing information on level of education. Of those receiving repair, 494 individuals had 
missing data on level of education. 
 
 
 
Figure X. To the left, annual incidence (x-axis) of intact abdominal aortic aneurysm (iAAA) (blue line) and ruptured 
AAA (rAAA)(red line) per 100,000 inhabitants aged ≥ 45. Screening for iAAA was initiated in 2006. Nationwide 
coverage was achieved in 2015. To the right, annual number of treated rAAA per time-period (blue staples, left 
axis) and the percentage treated with endovascular aortic repair (EVAR) (red line, right axis). 
 
0
10
20
30
40
50
60
70
80
20152013201120092007200520032001
200
300
400
500
600
700
800
900
0
10
20
30
40
50
60
70
80
90
100
2013-20152010-20122007-20092004-20062001-2003
 50 
A higher risk of presenting with a rAAA at time of index diagnosis was found for both low 
disposable household income and low level of education, table VI. After adjusting for age, sex 
and comorbid conditions, the association remained; OR 2.16 (95 % CI 1.98–2.36, p<.001) for 
Q1 and OR 1.33 (95 % CI 1.21–1.46, p<.001) for low level of education. Overall one-year 
mortality in rAAA patients was 76.5 % (6,096 of 7,968). Low disposable household income (Q1 
and Q2), adjusted for sex, age and comorbidities was associated with increased one-year 
mortality after rAAA repair; OR 1.49 (95 % CI 1.13–1.97, p=0.005). Low educational level did 
not influence survival after rAAA repair, table VI. 
 
Table VI. Associations between socioeconomic position indicators and presenting with ruptured, as opposed to 
intact abdominal aortic aneurysm as index-event and 90-day mortality after repair for ruptured abdominal aortic 
aneurysm (rAAA). 
 
Abbreviations: rAAA: ruptured abdominal aortic aneurysm, OR: odds ratio, CI: confidential interval, ref: reference. 
*Adjusted for sex, age (as a continuous variable) and comorbidity (Diabetes mellitus, hypertension, hyperlipidemia, 
chronic obstructive pulmonary disorder, stroke, heart disease, renal failure, malignancy). 
 
Study IV.  
A total of 10,724 individuals with rAAA were identified and included in the study, a minority 
were women (n=2,622, 24.4 %). The majority (n=8,498, 79.2 %) were found through the NPR, 
while the remaining 2,226 individuals (20.8 %) were found in the CDR.  
In the complete sample of 10,724 individuals, the association between female sex and not 
receiving repair reached significance with an ATE of -0.08 (95 % CI -0.106 – -0.055, p<.001). 
 rAAA as index diagnosis 
(n=7,968) 
90-day mortality (n=1,103) 
 Adjusted* Adjusted* 
 OR 95 % CI P OR 95 % CI P 
Disposable household income       
Q1 2.98 2.74–3.24 <.001 1.42 1.07–1.89 0.014 
Q2 2.37 2.18–2.59 <.001 1.36 1.03–1.80 0.031 
Q3 1.99 1.82–2.17 <.001 0.99 0.74–1.31 0.923 
Q4 1.48 1.35–1.62 <.001 1.07 0.80–1.43 0.661 
Q5 ref ref ref ref ref ref 
Level of education       
Low (up to 9 years) 1.52 1.38–1.68 <.001 1.31 0.98–1.76 0.068 
Middle (10–12 years) 1.12 1.02–1.22 0.023 1.22 0.89–1.66 0.210 
High (> 12 years) ref ref ref ref ref ref 
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These differences remained even after excluding individuals from the CDR register. The PSM 
model with the treated patients only (n=4,480) and EVAR as outcome was not significantly 
different between the sexes (ATE=-0.022, 95 % CI -0.049–0.005, p=0.109). Treated women had 
a higher postoperative mortality than men at 30 days, 90 days and 1 year, (ATE ranging from 
0.086–0.095), table VII.  
 
Table VII. Average difference in outcomes between sexes after propensity-score-matching. 
 
Propensity-score was calculated with the inclusion of the following covariates; age (as splines), year of diagnosis, 
diabetes, hypertension, hyperlipidemia, chronic obstructive pulmonary disease (COPD), renal failure, ischemic heart 
disease, cancer and SEP. For the last model, EVAR was added as a variable for the propensity-score calculation. 
 
 
 
 
 
 
 
 
Outcome Propensity-score-matched analysis on entire sample n=10,724 
 ATE 95 % CI P 
Treated -0.08 -0.106 – - 0.055 <.001 
    
 Propensity-score-matched analysis on in-patients only n=8,498 
 ATE 95 % CI P 
Treated -0.089 -0.119 – -0.060 <.001 
    
 Propensity score matched analysis on treated sample n=4,480 
 ATE 95 % CI P 
EVAR -0.022 -0.049–0.005 0.109 
    
 Propensity score matched analysis on treated sample n=4,480 
 ATE 95 % CI P 
30d mortality 0.094 0.053–0.135 <.001 
90d mortality 0.086 0.043–0.128 <.001 
One-year mortality 0.095 0.052–0.137 <.001 
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While male rAAA incidence declined rapidly, female incidence rates remained constant. After 
dividing the sexes into age-groups (<65, 65–74, 75–84 and >84 years), the time trends showed 
a steep decline in men aged 65–84 years, figure XI. Postoperative mortality declined over time 
but overall mortality did not, figure XII.  
 
 
Figure XI. Time trends in sex differences for patients with ruptured abdominal aortic aneurysm (rAAA). A. Total 
number of ruptures per year, blue line represents men, purple line represents women. B. Total number of ruptures 
per year according to age group.  
 
 
Figure XII. Time trends in sex differences for patients with ruptured abdominal aortic aneurysm (rAAA). Blue line 
represents male individuals, purple line represents female. A. Overall repair rates of all diagnosed patients with 
rAAA per year (dotted lines) and repair rates of all patients diagnosed in-hospital (connected lines). B. 
Postoperative 90-day mortality for treated rAAA (connected lines). Overall mortality for all individuals with rAAA 
(dotted lines). 
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Postoperative complication rates were similar for men (33.1 %) and women (35.1 %), p=0.210. 
The distribution of complications was equal in women and men. The three most common 
complications were: prolonged stay in the intensive care unit (ICU) >5 days, renal failure and 
multiple organ failure (MOF), figure XII.  
 
 
Figure XIII. Pie charts illustrating the distribution of complications in women (A) and men (B) after rAAA repair 
between 2009–2015.  
Abbreviations: ICU >5d=stay in intensive care unit >5 days, RF=Renal failure, MOF=Multiple organ failure. 
ACS=Abdominal compartment syndrome, MI= Myocardial infarction, CVL=Cerebrovascular lesion. 
 
5.2 DISCUSSION 
5.2.1 Untreated rAAA 
The rAAA demands early diagnostics and swift relay to the operating theatre or angio-suite. 
Left untreated or misdiagnosed, death is an almost certain entity. Even when treated, one in 
three suffer the same devastating result. For a long time, studies of AAA failed to include or 
report on the proportion untreated, a limitation also mentioned in a systematic review with 
meta-analysis of sex differences in morphological eligibility for EVAR.180 Failing to do so can 
lead to misunderstandings regarding rAAA epidemiology and its outcome. In Study I, the 
reported low proportion of untreated contradicts the previous assumption of high untreated 
rates.56, 70, 83 The higher proportion of untreated in a national setting from Study IV was partly 
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due to the inclusion of data from the CDR and hence differs from Study I where only individuals 
reaching an emergency department were included. However, when only including patients 
that were recorded in the NPR in Study IV, repair rates were 46 %, still lower than in our 
regional material. In the Stockholm county region where Study I was performed, an EVAR first 
strategy has been implemented during the last decade. From previously, where there was 
hesitation about transferring a patient with rAAA, more patients are now transported from 
their primary hospital to one of the two hospitals in the region with vascular expertise and 
resources. The benefits of this have been studied and reported on70 and are in concordance 
with current recommendations19. Increased use of EVAR might also allow older and more 
unwell patients to be eligible for repair as it can be performed without general anesthesia or 
laparotomy. 
5.2.2 Previously detected 
The immediate threat to life and the high mortality for rAAA calls for a high level of resources 
and skill within the hospital walls.70 However, early identification of patients with intact AAA in 
the population is the most effective tool to minimize the number of rAAA. Our second study 
(Study II) found that in one third of patients with rupture, the AAA was previously known. This 
is a high proportion and an aspect of the rAAA disease rarely studied or mentioned. Among the 
85 patients (30 %) with a previously known AAA, an alarmingly high proportion (31 %) were 
missed in surveillance or never referred to a vascular surgeon. This is an area in which care-
givers and health professionals must improve. Structured surveillance regimes must be 
developed, implemented and maintained. Furthermore, the awareness among health care 
providers regarding the necessity of referring AAA patients for evaluation at a vascular 
department must be enhanced.19 It is also important to recognize that surveillance is not only 
for preoperative use, but after EVAR, life-long surveillance with repeated imaging is important 
to avoid secondary sac rupture.181, 182 The influence of SEP, such as level of education, might 
be of importance in this aspect of previously detected AAA. Not fully understanding disease 
pathophysiology and risk assessments might impair patient compliance and prognosis, as 
further examined in Study III.  
5.2.3 When to treat AAA 
In Study II AAA-size as reason for non-repair comprised a small group (13 %) within the 
proportion of previously detected AAA among rAAA patients. Although rupture in patients with 
AAA diameter <55mm is rare, it can occur, and likewise, not all large AAA rupture. A systematic 
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review of 14 eligible studies concluded that rupture rates from small AAAs lie between 0 and 
1.61 per 100 person-years.183 However, heterogenicity among the studies and the absence of 
clear reporting standards for aneurysm rupture hindered the analysis. Suggestions that lower 
mortality after EVAR should prompt lower diameter threshold was discarded by a Cochrane 
analysis of four randomized trials.184 The 55 mm threshold is somewhat arbitrary but partly 
based on autopsy reports on 24,000 consecutive individuals.185 In that study, among those with 
AAA (473), 118 were ruptured. Approximately 40 % of AAAs >50 mm in diameter were 
ruptured. In the same study, 40 % of AAAs between 70 and 100 mm were not ruptured, 
whereas 13 % of AAAs <50 mm were ruptured. Perhaps the use of ASI80, 81 and consideration 
of other patient characteristics such as sex85, 170 and aneurysm morphology186, 187 could help 
determine which patients to operate on and when. Nevertheless, long-term prospective 
studies of these factors are necessary before inclusion in risk assessment protocols.  
5.2.4 Get rich or die trying 
Study III represents the largest study of individualized SEP and its effect on presentation of 
disease (iAAA or rAAA) set in a welfare-state such as Sweden. The effect of spending capability 
versus that of level of education is partly separate and the results in Study III might reflect this; 
a healthy lifestyle is associated with income and reflects the individuals capability of acquiring 
healthy foods, exercise and travel, whilst understanding disease pathophysiology and 
understanding when to seek care is often attributed to educational level157, 188. In the case of 
Study III, education may play a more important role in understanding disease and 
symptomology as well as adherence to screening programs, while income may affect overall 
cardiovascular comorbidity. The association between low SEP and presenting with rAAA rather 
than iAAA was seen in a Dutch study of 1,178 patients.164 The same results in Study III with 
41,222 patients further strengthens this association. Low SEP also affects screening 
attendance.30, 189 Study III and IV have indicated worse outcome for women and patients with 
low SEP. Even smoking, a main risk factor for AAA development and growth is associated with 
low SEP.190 The association between low SEP and worse outcome of AAA disease is therefore 
present from AAA formation, through growth and detection, to presentation and repair 
outcome. Information on SEP can be used to reduce smoking prevalence by targeted 
programs, to increase screening attendance by offering free screening and to improve patient 
outcome by better patient information and individualized surveillance both pre- and 
postoperatively.  
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5.2.5 Sex differences 
In both Study I and Study IV inequality between the sexes was examined at the regional and 
the national levels respectively. From Study I, the findings of similar repair rates and outcome 
were of great interest as they contradicted what, at that time, were sure assumptions of 
inequality in care between the sexes. What that study lacked however, was data on rAAA 
patients not admitted to a hospital and the results might only be applicable to a similar 
metropolitan area. The smaller population studied might also be grounds for type II errors. In 
Study IV sex differences in repair rates and short term outcome were clear. However, the lack 
of sex difference in long-term mortality seen in our sub group analysis could be a result of an 
overrepresentation of more comorbid male patients in the latter rupture cohort that has not 
adhered to screening programs. Some studies suggest similar results as Study IV.71, 84-86 
However there are contradicting reports191 that could be explained by differences in study 
variables and outcome measures. For instance, in our study a high proportion were treated 
with EVAR which was not the case in some of the other studies with opposing results71 and 
while Study IV presents both short and long-term data on postoperative mortality, others only 
present in-hospital data.86 Sex differences have been shown to be prominent in studies of iAAA 
where women are more often not offered repair, are less eligible for EVAR and have higher 
postoperative mortality.180 Study IV, one of the largest studies of sex differences in rAAA did 
not find women less eligible for EVAR but the difference in overall repair rates and 
postoperative mortality, especially 30-day mortality, was clear.  
5.2.6 Outcome 
Postoperative mortality rates after rAAA have improved, as shown in Study III and IV. The 
introduction of permissive hypotension and evidence-based blood transfusion regimes in rAAA 
patients192-194 might have improved survival outcome. Structured protocols or algorithms for 
managing rAAA have been shown to decrease the relative risk of 30-day mortality by 35 %.121 
Overall mortality after rAAA does not seem, however, to be in decline and is concordant with 
a study from Denmark that found that when adjusting for age, no change in overall mortality 
from rAAA was seen between 1994–2008.60 Similar results have been reported from 
Norway.110 Both these studies are from Nordic countries with similar health care systems as in 
Sweden. However, contradicting reports claim a decrease in rAAA mortality.25, 66, 67 These 
studies often lack the inclusion of out-of-hospital death and therefore may underestimate the 
overall mortality from rAAA.  
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5.3 METHODOLOGICAL CONSIDERATIONS 
All studies included in this thesis are to be considered observational studies, meaning that the 
researcher does not manipulate the exposure or influence the distribution of the exposure 
among the subjects. This is unlike the experimental study where the exposure is imposed on 
subjects by the researcher. This latter form of study is what is usually seen as a randomized 
trial, designed in an effort to erase confounders or at least have them evenly distributed 
between the different groups studied. Although this method is to be preferred when possible, 
certain conditions such as a rare disease or ethical considerations hinder a randomized trial 
and an observational study may better suit the cause. When matching is performed, different 
characteristics are taken into consideration in order to make the study groups as similar as 
possible so as to better assess the exposure effect.  
Study I and II. These studies only include those individuals who reached a hospital and were 
diagnosed with a rAAA either by clinical and/or radiological signs. We know that a proportion 
of rAAA patients die at home and with massively decreasing autopsy rates in Sweden for the 
elderly, the true incidence of rAAA will remain unknown. Subgroup analysis results in small 
number of patients being included, hence the results must be interpreted with caution. These 
studies represent the population of Stockholm and Gotland counties. A comparative study with 
the same outcomes from a more rural part of Sweden would have been interesting to perform. 
Study III. Although the CDR was included for the search for individuals with AAA disease, it still 
contains the same limitations as described for Study I and II. One must also consider whether 
autopsy rates differ among the SEP strata, possibly affecting the outcomes of this study. This 
has, however, not been shown to be evident.195 The study aimed to detect the initial diagnosis 
of AAA disease. To accomplish that, all registries were audited from 1995 onward but only 
those with an initial diagnosis of iAAA or rAAA between 2001–2015 were included. That left us 
with the assumption that the included individuals did not have a prior diagnosis before 1995. 
Level of disposable household income was extracted for the year prior to the initial diagnosis 
so as to reflect a full year’s income and better correlate with the income quintiles. The lack of 
smoking as a comorbidity factor is regrettable but difficult to manipulate, but chronic 
obstructive pulmonary disorder (COPD) was used as a proxy instead.  
Study IV. Today, the gold standard approach for estimating treatment effects is a RCT where 
the random allocation ensures that confounders, measured and unmeasured, will be evenly 
 58 
distributed between the groups. A PS analysis tries to mimic this fundamental quality of a RCT 
by accounting for differences in baseline characteristics. The PS is a balancing score, meaning 
that conditional on the PS, the distribution of measured baseline covariates is similar between 
treated and untreated subjects. In this current study, matching individuals on their PS and then 
observing the outcome (i.e. repair, EVAR or mortality after repair) one can assume that the 
compared women and men (1:3 ratio) are similar in all aspects except sex. This is comparable 
to the terms of a randomized trial setting where the randomization itself creates an even 
distribution of predictors. Unlike a regression model where confounders are inserted into the 
model because they affect exposure and outcome, a PS model incorporates confounders in 
the probability of the exposure (i.e. female sex in this study) and only on the combined PS does 
the model then predict outcome. The PS model has its limitations in that it only controls for 
variables inserted as predictors. Any missing or non-detected variable of importance cannot 
enter the model.  
5.3.1 External validity 
External validity describes the generalizability of the results to a larger demographic than the 
studied individuals. With the proper study design, a higher external validity can be achieved. 
Using population-based material is one way of achieving a high external validity but is only 
generalizable for the studied population. I.e., the results of Study I and II are generalizable to 
the counties of Stockholm and Gotland or to a county similar to these. Study III and IV are 
nationwide population-based studies and the results are therefore generalizable to all 
inhabitants in Sweden and also to similar countries with comparable health care systems and 
ethnic composition.  
5.3.2 Internal validity 
Internal validity describes to what extent the study correctly measures what it was intended to 
measure. Different types of errors or biases can impair the internal validity of a study. These 
are described below.  
5.3.3 Random error 
A random error generally affects the precision of the study rather than affecting the results in 
any one direction. In order to understand how this is estimated it is necessary to understand 
the basics of hypothesis testing. For every research question the “null hypothesis” should be 
  59 
defined, assuming that there is no correlation between the investigated exposure and 
outcome. Commonly used estimates of the level of random error include Confidence Interval 
(CI) and p-value. A 95 % CI states an interval within which the estimated result would fall 95 % 
of the time if the study was performed repeatedly under the same conditions. The p-value 
indicates the probability that the null hypothesis stands true despite the observed results. A 
Type-I error occurs when the null hypothesis is rejected despite being true. This can occur 
when multiple testing for significance is performed. A Type-II error occurs when the null 
hypothesis is accepted despite being false and is often due to insufficient power (small 
population) in the statistical analysis. The lack of sex differences in Study I may be due to a 
Type-II error as Study IV with a larger study population demonstrated opposing results. The 
loss of sex differences in the sub groups analysis performed in Study IV could be the result of a 
Type-II error as the included population was much smaller than the overall study group.  
5.3.4 Bias 
A selection process where selected subjects are not representative of the intended study 
population leads to selection bias. For this thesis, the rAAA diagnose comes with its inherent 
selection bias as an unknown proportion of rAAA patients die at home or in a hospital without 
autopsy or proper diagnosis. Although Study III and IV included data from the CDR, low autopsy 
rates cause possible selection bias, as does the inclusion of those patients only reaching an 
emergency department (Study I and II). Another form of bias, information bias or 
misclassification, occurs when different variables including exposure and outcome are 
registered or classified differently amongst subgroups in the study leading to an inherent 
skewness and error in comparing different groups. The Swedish NPR is validated with 
extremely good coverage of inpatient data.176  
5.3.5 Confounder 
A variable that is associated with both the exposure and the measured outcome is called a 
confounder. In a randomized trial the confounders are assumed to be evenly distributed so as 
not to cause any interference with the results. In observational studies, however, confounders 
must be identified so that they can be adjusted for in the model or to help stratify the study 
groups. For AAA disease, age is a typical confounder affecting both the development of the 
disease (exposure) and postoperative mortality (outcome). Both Study III and IV incorporate 
and adjust for this in their statistical models.  
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6 CONCLUSIONS 
Apparent positive trends in the care of men with rAAA can be found that could be partly 
associated with the implementation of screening, and possibly improved cardiovascular 
prevention in the population. However, the results unfortunately do not reflect equally in the 
female population. Alarmingly, our results emphasize the presence of inequality in the health 
care system for women and those with low income and low level of education.  
Study I. Our results and other contemporary studies show a shift toward a higher rate of 
treated patients with rAAA, and improving outcomes, similar for women and men. The 
increased use of EVAR contributes to this improvement in short-term outcome. High age 
influences the willingness to treat patients with rAAA. 
 
Study II. One-third of patients admitted with a rAAA had a previously detected AAA. The 
surgeon’s decision to deny elective surgery and surveillance deficiency were the two main 
reasons for non-repair at time of the AAA diagnosis. Improved patient-specific protocols to 
reduce the surveillance gaps and new methods of determining rupture risk in each case of 
AAA could be two possible future strategies to reduce the incidence of rupture. 
 
Study III. The incidence of rAAA is decreasing. Individuals with low SEP have a higher risk of 
presenting with rAAA rather than iAAA. They also fare worse after repair. Consequently, SEP 
should be regarded as a relevant risk factor that should be included in considerations for 
improved care flow of patients with AAA. 
 
Study IV. Female sex is associated with lower repair rates and higher mortality after repair for 
rAAA, the latter was most evident for 30-day mortality. No difference was observed in the 
association between sex and repair type.  
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7 FUTURE PERSPECTIVES 
 
Studies on targeted screening invitations to individuals with low SEP as well as possible changes 
to patient fees should be performed to determine if screening attendance improves.  
Further studies of subgroups of small AAA among women should be initiated to better clarify 
if threshold diameter for intervention for women should be lowered to avoid rupture in this 
group. A large RCT that is not underpowered would be ideal, including subgroups of smoking 
and non-smoking women.  
SWEDVASC has improved its coverage yearly and is now a good platform to use for further 
research into AAA disease and vascular surgery in general. The collection of data on smoking 
habits is a useful variable in the registry that could be used in future studies. 
Studies on the association between SEP and iAAA are a natural next step to see if differences 
are also evident in the patient with an iAAA. So is studying the proportion of previously 
detected AAA in rAAA patients on a nationwide basis, as well as observing differences in those 
rates over time. 
The findings in Study III and IV also have implications beyond AAA and vascular surgery.  
Sex differences are evident not only in AAA disease but many other areas of interest such as 
malignant melanoma. Using Swedish register data and data from the Swedish cancer registry, 
this area can be further explored.  
Differences in SEP have implications in other fields of surgery such as breast cancer, breast 
cancer reconstruction and other malignancies. It would be advisable to study this further in 
those clinical settings.  
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